Business Wire

Baxter Provides Update on COVID-19 Response Efforts

Share

Baxter International Inc. (NYSE:BAX), a global medical products company, today provided an update on how the company is responding to the COVID-19 epidemic that is challenging communities and healthcare systems throughout the world. The company’s support remains focused on increasing supply of its life-sustaining medicines and medical devices amidst unprecedented, rising demand; protecting employee health and safety; expanding job opportunities globally to help meet increased product demand; and providing philanthropic grants to support impacted communities.

"Baxter’s mission is to Save and Sustain Lives, and that commitment guides everything we do – even when the obstacles seem greatest,” said José (Joe) E. Almeida, chairman and chief executive officer. “The heroic work by healthcare providers and first responders to care for those with COVID-19 inspires us all. We are committed to doing everything we can to support the healthcare system, our employees and our communities during this unprecedented time."

Increasing Product Supply & Distribution

Since the emergence of COVID-19 and associated surge of patient hospitalizations, demand for certain Baxter products has increased significantly compared to normal ordering levels. In turn, Baxter has boosted its capacity and production to help address higher demand for products including PrisMax and Prismaflex, the company’s blood purification systems used to treat acute kidney injury and other conditions, along with the solutions and consumables that enable them; its Mini-Bag Plus drug delivery system; the Spectrum IQ Infusion System and accompanying I.V. administration sets; I.V. solutions; and injectable drugs used in the ICU and across the hospital. All Baxter facilities manufacturing these products are maximizing production levels and continuing to pursue all opportunities to further increase supply, enabling the company to deliver as much as possible for those medical devices and medicines that are in high demand.

“Our medically essential products put us on the front lines of this pandemic, and our 50,000 colleagues are rising to the challenge to make a meaningful difference for patients,” said Almeida. “Given that demand is at extraordinary levels, it is critical that we prioritize getting our products where they are most needed – hospitals that are being overwhelmed by an influx of patients who are critically ill from COVID-19.”

Baxter’s process for product allocations during the COVID-19 pandemic is based on specific criteria that helps deliver the company’s life-saving products where they are needed the most. These efforts are informed in part from objective research sources, such as the Institute for Health Metrics and Evaluation, government data reporting, such as U.S. Centers for Disease Control and Prevention, and academic data, such as Johns Hopkins University & Medicine Coronavirus Resource Center. While current customers will continue to have access to Baxter products, this process will strive to dedicate additional inventory to hospitals around the world with the greatest COVID-19 patient care needs and will be updated regularly to reflect the dynamic situation.

Baxter is increasing its access to air freight capacity as well as the frequency of transporting critically needed medical devices and medicines back and forth between the U.S. and Europe. Flights will start this week, and the new airbridge will help the company get more products to hospitals as quickly as possible. Baxter continues to aggressively monitor the availability of, and source incremental, raw materials and components to help ensure supply continuity. The company also remains focused on supporting patients with chronic diseases who rely on life-sustaining Baxter therapies, including parenteral nutrition and dialysis.

Protecting Employee Health & Safety

Baxter’s staged pandemic response plan, which follows guidelines from the Centers for Disease Control and the World Health Organization, is active across all facilities globally. The response plan includes protective measures such as enhanced infection control actions, remote working arrangements for office-based employees, restricted travel, symptom screening at building entrances, and use of personal protective equipment by employees. Manufacturing operations have also been modified to limit interactions between employee groups.

Baxter’s manufacturing, quality, warehousing, delivery, field service employees and Renal Care Services employees continue their work to help ensure the company’s products remain at the ready to treat patients around the globe. In recognition of the extraordinary role these employees hold in the supply of medical products to hospitals and patient homes, the company has instituted a special pandemic incentive for its front-line workers. In addition, the company has implemented a volunteerism program, which provides an avenue for Baxter employees with appropriate medical training and licensure, including physicians and nurses, to take a leave of absence from the company and volunteer within their communities.

Expanding Employment Opportunities

Amidst significant economic disruption, increased demand for the company’s products is creating additional permanent and temporary employment opportunities – up to 2,000 new positions globally, 800 of which are in the United States. The company is looking for talented and passionate individuals to join in a variety of roles worldwide, primarily in manufacturing to help bolster production. Roles are available for those with minimal experience in manufacturing and will include robust training. More information on available jobs is at www.baxter.com/careers.

Donations for Humanitarian Relief

The Baxter International Foundation is providing more than $2 million in financial support for humanitarian relief organizations on the front lines of the pandemic globally. This includes a $1 million grant to Save the Children, who is working around the world to provide supplies, training, and information to prevent the pandemic, in addition to comprehensive efforts to strengthen communities and keep children and families safe—supporting food security, helping children continue to learn, and more. It also includes support for World Vision’s COVID-19 Global Emergency Response, and geographic-specific support to Direct Relief in Europe, Project Hope in Asia, Americares in Latin America and the iBio Institute and local United Way chapters in the Chicagoland area. These latest donations build on initial grants to the global United Nations Foundation/WHO COVID-19 Solidarity Response Fund, IsraAID and Partners in Health. Finally, the Foundation is supporting its pre-existing grantee base by providing options to reallocate and/or extend funds as appropriate during this time.

About Baxter

Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on Twitter, LinkedIn and Facebook.

Rx Only. For the safe and proper use of the devices referenced here, refer to the complete Instructions for Use or the appropriate operator’s manual.

Important Safety Information

The PrisMax and Prismaflex systems are intended for:

CRRT for patients weighing 20 kg or more with acute renal failure and/or fluid overload.

TPE therapy for patients weighing 20 kg or more with diseases where removal of plasma components is indicated.

All treatments administered via the PrisMax and Prismaflex control units must be prescribed by a physician.

This release includes forward-looking statements concerning the company’s response to the COVID-19 epidemic, including with respect to the company’s ability to support heightened product demand levels (through the new airbridge or otherwise) and to make product allocations based on need and its plans to hire additional employees. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: ability to maintain supply continuity; actions of regulatory bodies and other governmental authorities; contractual requirements, product quality, manufacturing or supply, or patient safety issues; changes in law and regulations; and other risks identified in Baxter's most recent filing on Form 10-K and other SEC filings, all of which are available on Baxter's website. Baxter does not undertake to update its forward-looking statements.

Baxter, PrisMax, Prismaflex, Mini-Bag Plus and Spectrum IQ are registered trademarks of Baxter International Inc.

Contact information

Media Contact
Lauren Russ, (224) 948-5353
media@baxter.com

Investor Contact
Clare Trachtman, (224) 948-3020

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Saudi Urban20 Chair Wishes Italy ‘Buona Fortuna’ With the 2021 Urban20 Presidency26.11.2020 14:47:00 CETPress release

TheUrban20 (U20) Chair, His Excellency Fahd Al-Rasheed, President of the Royal Commission for Riyadh City has today wished his Italian counterparts good luck or “Buona Fortuna” as Italy prepares to take up the reins of the 2021 G20 Presidency and the engagement group of cities, the U20. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201126005650/en/ HE Fahd Al-Rasheed, chair of U20 Riyadh 2020 - (Photo - AETOSWire) “The city of Riyadh is immensely proud and honored to have Chaired the 2020 U20. We are proud of the progress we made together as the U20 of 42 cities and 30 think tanks, universities, and multi-lateral entities. We collaborated, innovated and found common ground. We discussed challenges and solutions experienced by cities across every continent. We focused on the common goal of rebuilding better. As we worked to bring urban issues to the fore, a record 39 mayors and representatives of leading cities endorsed the

DEWA Innovation Centre and 800MW 3rd Phase of the Mohammed bin Rashid Al Maktoum Solar Park Inaugurated26.11.2020 14:31:00 CETPress release

HH Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, has inaugurated Dubai Electricity and Water Authority’s (DEWA’s) Innovation Centre and the 800MW third phase of the Mohammed bin Rashid Al Maktoum Solar Park, the largest single-site solar park in the world. The solar park has a planned capacity of 5,000MW by 2030, with investments up to AED50 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201126005645/en/ DEWA Innovation Centre and 800MW 3rd phase of the Mohammed bin Rashid Al Maktoum Solar Park inaugurated (Photo: AETOSWire) HH Sheikh Mohammed bin Rashid Al Maktoum was briefed by HE Saeed Mohammed Al Tayer, MD & CEO of DEWA, about the Innovation Centre, which is a global hub for renewable and clean energy innovation. It supports innovation and creativity in clean and renewable energy, promotes sustainability, develops Emirati talent and enhances the UAE’s com

Leveraging Its Mobile ID, IDEMIA Brings Digital Travel Credentials to Life26.11.2020 14:30:00 CETPress release

Digital Travel Credentials make traveling between airports and airlines a more enjoyable experience and bolsters passenger trust in airport services and systems. On 10-11 November 2020, at the ICAO virtual conference, IDEMIA demonstrated with an airline partner its breakthrough innovation capabilities to present a fully operational solution, bringing DTC to life. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201126005534/en/ (Photo: Buiness Wire) Leveraging its Mobile ID solution and passenger flow facilitation solutions, IDEMIA simulated a passenger DTC for check in and smart boarding. Passengers can speed through all airport touchpoints thanks to fast and ultra-secure biometric identification. IDEMIA’s DTC treat private data with the same security level as for paper passports. “This DTC demonstrator illustrates the innovative capabilities of IDEMIA to perform a highly secure, reliable and smooth identity verification of t

Egle Therapeutics Identifies First Novel Regulatory T-cell Targets in Research Alliance with Takeda26.11.2020 11:30:00 CETPress release

Egle Therapeutics SAS (Egle), an emerging biotechnology company focused on developing first-in class immunotherapies targeting immune suppressor regulatory T-cells (Tregs) for oncology and autoimmune diseases, today announces that it has achieved the first milestone in its strategic research alliance with Takeda Pharmaceutical Company Limited (“Takeda”). In the course of the strategic research alliance that was announced in June 2020, Egle will validate novel tumor-infiltrating regulatory T-cell (Treg) targets against which Takeda will develop potential therapies. Egle has leveraged its unique bioinformatic and translational capabilities to successfully identify targets that will now be pursued under the terms of the alliance. Upon achievement of the target identification, Egle will receive an R&D milestone payment and investment from Takeda. Luc Boblet, CEO of Egle, commented “Reaching this first technical milestone marks our positive progress towards our joint goal with Takeda, of cr

Technology Entrepreneurs Choose Chengdu as Destination and Benefit From the City’s International Business-Friendly Environment26.11.2020 09:23:00 CETPress release

Chengdu has long had an international reputation as a highly livable city. In recent years, Chengdu has also cultivated a business-friendly environment aligned with international standards, making the city fertile soil for enterprise development, especially in the tech sector. XGIMI Technology, a Chengdu-based leading provider of multi-functional smart projectors and laser TVs in China, attributed part of its success to Chengdu’s favorable environment, helping the firm to grow and in 2018 surpass global giants Epson and Sony in the Chinese projector market for the first time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201126005495/en/ XGIMI Technology Founder Mr. Zhong Bo (Photo: Business Wire) According to data on China’s projector market in the first half of 2020 released by IDC, XGIMI ranked first in terms of shipments and sales, with a market share of 22%. Five XGMI models feature in the top ten projectors by shipmen

Lexon’s Oblio Named as One of TIME’s 100 Best Inventions Of 202026.11.2020 08:57:00 CETPress release

20 years after making the cover of TIME with their flagship Tykho radio, French design brand Lexon is back on the prestigious publication to reiterate its mission to continuously create disruptive, useful and affordable design objects that improve our daily lives. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201125005899/en/ Oblio (Photo: Business Wire) More than just highlighting the groundbreaking French invention, TIME award confirms Oblio’s position as a must-have innovation for today’s world, as it has been crafted in-house primarily as a sleek UV-C sanitizer to prevent the spread of harmful viruses and bacteria that are found on our smartphones, using its built-in UV-C LED technology located on its front interior. UV-C LEDs destroy and eradicate the DNA of microorganisms found in viruses, bacteria, mold, and germs. Capable of fully sanitizing a single surface at a time, Oblio can deliver a 360° disinfection by simply

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom